24Mar2023 Read more More Than 190 Groups Applaud Bipartisan Federal Legislation to Ensure Senior Access to Essential Pharmacist Services & Strengthen Our Nation’s Public Health Response H.R. 1770 Would Provide Payment for Pharmacist Services for COVID-19, Flu, Strep & RSV Under Medicare Part B and Ensure Pharmacists Can Continue to Protect Vulnerable Senior Communities
20Mar2023 Read more APhA applauds new federal bipartisan PBM legislation The American Pharmacists Association (APhA) applauds the introduction of the Drug Price Transparency in Medicaid Act, which would reign in PBMs’ unfair and anticompetitive business practices that are harming the viability of our nation’s pharmacies.
17Mar2023 Read more FDA finalizes guidance on definitions of “suspect product” and “illegitimate product” for existing verification obligations under DSCSA FDA released final guidance this week that will help dispensers better understand their obligations under the Drug Supply Chain Security Act (DSCSA) related to “suspect” and “illegitimate” products.
16Mar2023 Read more APhA and NASPA Release Fourth and Year-end Pharmacy Workplace and Well-being Reporting (PWWR) Findings WASHINGTON, DC— Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the fourth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and findings report series.